Featured Articles

  1. ICH E6(R3): 10 FAQ On What Changed And What It Means For Your Trials 9/18/2025

    The ICH E6(R3) updated guidelines present 10 critical changes to make clinical trials more efficient, adaptable, and patient-centric, while upholding the standards of scientific and ethical integrity.

  2. Inclusive Trial Design A 'Must-Have' In Modern R&D 8/14/2025

    Inclusivity in trial design is a crucial aspect of the R&D process, recognized for its importance to ensuring scientific validity, ethical responsibility, and public health.

  3. Gene Therapy Studies Rose While Financing Declined In Q2 2025 8/13/2025

    There were three new approvals across the therapeutic landscape in the second quarter of 2025, but despite those positive signs, overall dealmaking was flat for the quarter.

  4. Completed Trials Climb At Faster Pace 8/13/2025

    In 2024, the number of industry-sponsored clinical trials reaching completion accelerated significantly. Explore the trial counts and rankings, top 5 diseases for trials, and more.

  5. RWD, New Technologies Show Potential In Clinical Trial Recruitment 7/10/2025

    Leveraging RWD transforms feasibility and recruitment from reactive processes into strategic drivers of clinical trial success.

  6. Clinical Trials Need To Take The Whole Patient Into Account 7/10/2025

    Explore how inclusivity in clinical trials needs to encompass the whole patient, taking into account factors like race, sex, age, ethnicity, sexual orientation, and physical abilities or qualities.

  7. Use Case: How Consulting & Analytics Can Guide Clinical Strategy 7/10/2025

    A large European pharmaceutical company sought to benchmark a CRO’s suggestions involving a Phase III trial for a newly acquired asset.

  8. 8 Tips For Producing Masterful Plain Language Summaries 7/10/2025

    Following these tips will ensure high-quality plain language summaries (PLS) that meet EU parameters while clearly communicating clinical trial information to patients and the public.

  9. Sickle Cell Cure Within Reach, But At A Steep Cost 7/10/2025

    Treatment options for sickle cell disease (SCD) and newly available gene therapies represent a potential cure. However, the latter are costly and thus remain out of reach for many SCD patients.

  10. Disclosure Management System: Build Or Buy? 6/19/2025

    Clinical trial disclosure regulations are tightening worldwide. In order to maintain compliance, sponsors must determine whether to build an internal disclosure management system or buy a solution.